The probe DBT-2EEGIHGHHIISVG enables the targeted visualization of LAPTM4B in human HCC cells, and selective and high-contrast imaging of LAPTM4B protein-expressing tumor tissues in live mice, which has the potential to make LAPTM4B useful in the treatment of HCC (110). This evidence concerns the gene LAPTM4B and hepatocellular carcinoma.